RxDoctor Payments Data

Kit Tam

Hematology & Oncology · Sacramento, CANPI 1972732014

Payments from drug & device makers

What this record shows

That places this record below the midpoint for hematology & oncology clinicians in CA, where the typical reported total is $3,371.

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

$216,046in research payments, 2019–2025

Across 6 payments — averaging $36,008 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • E.r. Squibb & Sons, L.L.C.$216K

How this compares

$0 in reported general payments places this provider in the 0th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Medicare billing

Part B allowed, 2024
$102,144
Medicare patients
165
Services billed
1,524

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sunitinib Malate14$102,337
BraftoviEncorafenib12$96,496
EliquisApixaban12$12,946
Ondansetron Hcl51$717
LoperamideLoperamide Hcl25$491
Prochlorperazine Maleate33$460
Lidocaine Hcl ViscousLidocaine Hcl18$340
Oxycodone Hcl24$310
Dexamethasone14$133

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Sacramento

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →